Details for Patent: 8,865,698
✉ Email this page to a colleague
Which drugs does patent 8,865,698 protect, and when does it expire?
Patent 8,865,698 protects VITRAKVI and is included in two NDAs.
This patent has one hundred and eleven patent family members in thirty-eight countries.
Summary for Patent: 8,865,698
| Title: | Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds |
| Abstract: | Provided herein are methods for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal, which comprises administering to said mammal in need thereof a therapeutically effective amount of a compound of Formula I: ##STR00001## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, X, Y and n have the meanings given in the specification. |
| Inventor(s): | Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Niwot, CO) |
| Assignee: | Array BioPharma Inc. (Boulder, CO) |
| Application Number: | 13/943,590 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,865,698
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861-001 | Nov 26, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING CANCEROUS SOLID TUMORS | ⤷ Sign Up | ||||
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861-002 | Nov 26, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING CANCEROUS SOLID TUMORS | ⤷ Sign Up | ||||
| Bayer Healthcare | VITRAKVI | larotrectinib sulfate | SOLUTION;ORAL | 211710-001 | Nov 26, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING CANCEROUS SOLID TUMORS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,865,698
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3106463 | ⤷ Sign Up | 301033 | Netherlands | ⤷ Sign Up |
| European Patent Office | 3106463 | ⤷ Sign Up | PA2020504 | Lithuania | ⤷ Sign Up |
| European Patent Office | 3106463 | ⤷ Sign Up | CA 2020 00013 | Denmark | ⤷ Sign Up |
| European Patent Office | 3106463 | ⤷ Sign Up | 122020000012 | Germany | ⤷ Sign Up |
| European Patent Office | 3106463 | ⤷ Sign Up | LUC00150 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 3106463 | ⤷ Sign Up | 2020C/507 | Belgium | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
